63850-0058 : Everolimus 2.5 mg Oral Tablet


NDC: 63850-0058
Labeler: Natco Pharma Limited
Product Type: Human Prescription Drug
Drug Name:  Everolimus
Dosage Form: Oral Tablet
Application #: ANDA205426
Rev. Date: 


NDC Package Codes:

  • 63850-0058-1: 4 BLISTER PACK IN 1 CARTON (63850‑0058‑1) > 7 TABLET IN 1 BLISTER PACK
  • 63850-0058-4: 30 TABLET IN 1 BOTTLE (63850‑0058‑4)

Active Ingredients:

  • Everolimus

Dosage Strength:

  • 2.5 mg

Pharmaceutical Classes:

  • Kinase Inhibitor [EPC]
  • Protein Kinase Inhibitors [MoA]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]
  • Cytochrome P450 2D6 Inhibitors [MoA]
  • mTOR Inhibitor Immunosuppressant [EPC]
  • mTOR Inhibitors [MoA]
  • Decreased Immunologic Activity [PE]

Related Products:

Based on records with the same trade name.
  • 63850-0059 Everolimus 5 mg Oral Tablet by Natco Pharma Limited
  • 63850-0060 Everolimus 7.5 mg Oral Tablet by Natco Pharma Limited
  • 63850-0061 Everolimus 10 mg Oral Tablet by Natco Pharma Limited
  • 63850-0062 Everolimus .25 mg Oral Tablet by Natco Pharma Limited
  • 63850-0063 Everolimus .5 mg Oral Tablet by Natco Pharma Limited
  • 63850-0064 Everolimus .75 mg Oral Tablet by Natco Pharma Limited
  • 0054-0470 Everolimus .25 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0471 Everolimus .5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0472 Everolimus .75 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0480 Everolimus 2.5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0481 Everolimus 5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0482 Everolimus 10 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0497 Everolimus 7.5 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0054-0604 Everolimus 1 mg Oral Tablet by Hikma Pharmaceuticals USA Inc.
  • 0093-7766 Everolimus 2.5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0093-7767 Everolimus 5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0093-7768 Everolimus 7.5 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0093-7769 Everolimus 10 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0378-0005 Everolimus 2 mg Oral Tablet, for Suspension by Mylan Pharmaceuticals Inc.
  • 0378-0006 Everolimus 3 mg Oral Tablet, for Suspension by Mylan Pharmaceuticals Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 63850-0058 QR Code

< Prev: 63850-0056Next: 63850-0059 >

Related Discussions:

Everolimus Face Rash
Side Effects of Everolimus including face and body rash; swollen feet...
Everolimus Side Effects
Everolimus Side Effects: Face and Body Rash...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.